The Effects of a Nitrate Supplementation on Erectile Function - Trial NCT06213077

Timeline & Enrollment

Primary Outcome

International Index of Erectile Function,Erection Hardness Score

Summary

Twenty (20) individuals to be recruited from Ballantyne Medical Associates in Charlotte, NC,
 without any significant chronic medical history. These patients are general patients for
 primary care that meet inclusion criteria. Patients will be screened and enrolled by Dr.
 Bauer and his delegated research staff upon patient consult. Patients will be informed of the
 purpose of the study including risks, benefits, and alternative treatments to the study.
 After the potential participants have been given the opportunity to ask questions and have
 their questions answered, they will be asked to sign an informed consent prior to any
 study-specific procedures being performed.
 
 Blinded test product will be randomly assigned to study subjects. Test group 1 will be dosed
 with a placebo capsule taken two capsules once daily Test group 2 will be dosed with Berkeley
 Life capsules taken two capsules once daily. At baseline, prior to crossover to the other
 treatment, and at the study's conclusion, NO levels will be monitored using salivary nitric
 oxide test strips. Both test groups will remain on their existing treatment protocol
 throughout the study.

ICD-10 Classifications